CAS NO.: 1834612-06-4
Synonyms: N/A
Molecular Formula: N/A
Molecular Weight: N/A
Application: Lumasiran sodium is an investigational RNA interference (RNAi) therapeutic agent, reduces hepatic oxalate production by targeting glycolate oxidase. Lumasiran sodium reduces urinary oxalate excretion, the cause of progressive kidney failure in primary hyperoxaluria type 1 (PH1).
Any product involved in patent will be used for research purposes only.